Category: Prostate Cancer

According to statistics, not all men with prostate cancer are created equal. Statistics from the National Institutes of Health tell a sad tale: black men have about a 1.5 – 2 times greater chance of developing prostate cancer (at least 15% vs. 10% respectively; are more often diagnosed with aggressive PCa; and the risk of keep reading

Question: Does the body naturally kill cancer cells? Answer: Yes, especially if the immune system gets by with a little help from exercise. A multinational team may have decoded a mysterious link between exercise and one of the body’s own resources for destroying cancer cells. In October, 2020, Rundqvist, et al. published “Cytotoxic T-cells mediate keep reading

The FDA-approved PCA3 urine test (Progensa) for detecting a biomarker that is overexpressed in prostate cancer (PCa) was acknowledged by the American Urological Association as far back as 2013 as a useful adjunct – along with other PSA derivatives – for determining if a biopsy or repeat biopsy was needed. keep reading

Benign prostatic hyperplasia, or BPH, is a common prostate enlargement as men age. It is estimated that at least 40% of men have BPH during their fifties, increasing to 90% of men in their eighties. Many men are not troubled by it, but it can create urinary difficulties if the enlargement narrows the urethral passage from the bladder out of the body. keep reading

Despite cancer warnings, let’s face it. Untold millions of meat-lovers—and the restaurants that cater to them—continue to grill meat over high heat or open flames. As we wrote in the original blog, this causes the formation of carcinogens called heterocyclic aromatic amines (HAAs). keep reading

In January, 2018 we posted a blog on several spices that have an observed anti-cancer affect when laboratory-tested on cancer cells or animals. This update focuses on turmeric and a compound derived from it, curcumin. Curcumin has been shown to... keep reading

Here is more recent news about a genomic analysis of prostate tissue from men in the study described below who developed prostate cancer. The research team, including some authors from the original study, tested for trends in gene expression according to the level of ejaculation frequency... keep reading

Research supports the anti-tumor effect of non-psychoactive CBD (cannabidiol), one of 100+ identified plant-derived cannabinoid compounds. For example, Kis et al. note that lab studies have shown a chemopreventive effect of cannabidiol in prostate cancer... keep reading

Here it is, December of 2020. It’s been the Year of the Pandemic, and possibly also the Year of Increased Drinking. A September 29 ABC News story reported a sharp increase in U.S. alcohol consumption—especially among women—perhaps as a way to cope with feelings of isolation, depression and anxiety. keep reading

Here is fantastic news for men who undergo an initial treatment for localized prostate cancer! In November, 2020 the U.S. Food and Drug Administration (FDA) granted Fast Track Designation to RV001, an investigational vaccine against prostate cancer recurrence after primary treatment. RV001 is manufactured by a Swedish pharmaceutical company called RhoVac. Let’s look at the keep reading